Literature DB >> 32725254

Psoriasis and Dementia: A Cross-sectional Study of 121,801 Patients.

Khalaf Kridin1, Dennis Linder, Guy Shalom, Stefano Piaserico, Meir Babaev, Tamar Freud, Doron Comaneshter, Arnon D Cohen.   

Abstract

Data regarding the association between psoriasis and dementia are inconclusive. The aim of this study was to evaluate this association in the database of Clalit Health Services, Israel. A comparative analysis for the association between psoriasis, dementia and its risk factors was performed for the entire study population and in the subgroup of patients with moderate-to-severe psoriasis. The study included 121,801 patients with psoriasis, of whom 16,947 were diagnosed with moderate-to-severe psoriasis, and 121,802 controls. Psoriasis was associated with a lower prevalence of dementia relative to control subjects (1.6% vs 1.8%; odds ratio (OR) 0.85; 95% confidence interval (95% CI) 0.80-0.91; p < 0.001). Multivariate analysis adjusting for demographic variables, cardiovascular-related risk factors, and healthcare utilization demonstrated a significant inverse association between psoriasis and dementia in the entire study population (adjusted OR 0.86; 95% CI 0.76-0.96; p = 0.009), but not in the subgroup of patients with moderate-to-severe psoriasis (adjusted OR 0.91; 95% CI 0.81-1.02; p = 0.113). In conclusion, these data support the hypothesis that psoriasis is inversely associated with dementia.

Entities:  

Keywords:  dementia; depression; diabetes; hyperlipidaemia; hypertension; obesity; psoriasis

Mesh:

Year:  2020        PMID: 32725254      PMCID: PMC9207629          DOI: 10.2340/00015555-3595

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   3.875


  32 in total

Review 1.  Molecular Signaling Mechanisms of Natural and Synthetic Retinoids for Inhibition of Pathogenesis in Alzheimer's Disease.

Authors:  Mrinmay Chakrabarti; Alexander J McDonald; J Will Reed; Melissa A Moss; Bhaskar C Das; Swapan K Ray
Journal:  J Alzheimers Dis       Date:  2016       Impact factor: 4.472

Review 2.  The neuropathology and cerebrovascular mechanisms of dementia.

Authors:  Limor Raz; Janice Knoefel; Kiran Bhaskar
Journal:  J Cereb Blood Flow Metab       Date:  2016-01       Impact factor: 6.200

3.  [The quality indigators program in Clalit Health Services: the first decade].

Authors:  Arnon D Cohen; Jacob Dreiher; Sigal Regev-Rosenberg; Orit Yakovson; Nicky Lieberman; Margalit Goldfracht; Ran D Balicer
Journal:  Harefuah       Date:  2010-04

Review 4.  Cognitive impairment in major depression and the mGlu2 receptor as a therapeutic target.

Authors:  Celia Goeldner; Theresa M Ballard; Frederic Knoflach; Juergen Wichmann; Silvia Gatti; Daniel Umbricht
Journal:  Neuropharmacology       Date:  2012-08-23       Impact factor: 5.250

Review 5.  Psoriasis.

Authors:  Wolf-Henning Boehncke; Michael P Schön
Journal:  Lancet       Date:  2015-05-27       Impact factor: 79.321

Review 6.  Retinoids for treatment of Alzheimer's disease.

Authors:  Alan J Lerner; Kasia Gustaw-Rothenberg; Shawn Smyth; Gemma Casadesus
Journal:  Biofactors       Date:  2012-03-15       Impact factor: 6.113

7.  Systemic Therapy for Psoriasis and the Risk of Herpes Zoster: A 500,000 Person-year Study.

Authors:  Guy Shalom; Devy Zisman; Haim Bitterman; Ilana Harman-Boehm; Sari Greenberg-Dotan; Jacob Dreiher; Ilan Feldhamer; Hadas Moser; Ariel Hammerman; Yoram Cohen; Arnon D Cohen
Journal:  JAMA Dermatol       Date:  2015-05       Impact factor: 10.282

8.  The risk of depression, anxiety, and suicidality in patients with psoriasis: a population-based cohort study.

Authors:  Shanu Kohli Kurd; Andrea B Troxel; Paul Crits-Christoph; Joel M Gelfand
Journal:  Arch Dermatol       Date:  2010-08

Review 9.  Possible role of vascular risk factors in Alzheimer's disease and vascular dementia.

Authors:  Mehrul Hasnain; W Victor R Vieweg
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

10.  Psoriasis is not associated with cognition, brain imaging markers, and risk for dementia: The Rotterdam Study.

Authors:  Elena Pezzolo; Unal Mutlu; Meike W Vernooij; Emmilia A Dowlatshahi; Paolo Gisondi; Giampiero Girolomoni; Tamar Nijsten; M Arfan Ikram; Marlies Wakkee
Journal:  J Am Acad Dermatol       Date:  2018-08-06       Impact factor: 11.527

View more
  3 in total

Review 1.  The link between cutaneous inflammation and cognitive impairment.

Authors:  S Wen; P M Elias; J S Wakefield; T M Mauro; M-Q Man
Journal:  J Eur Acad Dermatol Venereol       Date:  2022-07-02       Impact factor: 9.228

2.  Cognitive Functions Associated with Brain Imaging Markers in Patients with Psoriasis.

Authors:  Luiza Marek-Jozefowicz; Adam Lemanowicz; Małgorzata Grochocka; Monika Wróblewska; Katarzyna Białczyk; Katarzyna Piec; Grzegorz M Kozera; Zbigniew Serafin; Rafał Czajkowski; Alina Borkowska
Journal:  Int J Environ Res Public Health       Date:  2022-05-07       Impact factor: 4.614

3.  Prevalence of Tobacco Smoking and Its Association With Disease Severity Among Patients With Psoriasis in China: A Cross-Sectional Study.

Authors:  Lei Wei; Siting Chen; Zhan Zhang; Le Kuai; Rui Zhang; Ning Yu; Yuling Shi; Bin Li; Ruiping Wang
Journal:  Front Med (Lausanne)       Date:  2022-05-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.